JAMARCUS HERSHBERGER: Open Payments
NPI 1457932329 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 42 payments from 11 companies in 2025. Trend: 2023 $1,024 · 2024 $1,230 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $141 |
| Alkermes, Inc. | 6 | $121 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| ABBVIE INC. | 3 | $47 |
| Lundbeck LLC | 1 | $25 |
| Neos Therapeutics, LP | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: REXULTI, TRINTELLIX, ARISTADA, SPRAVATO, CAPLYTA, AUSTEDO XR, VRAYLAR, LYBALVI.
Industry payments across OH — which companies pay providers there.
